¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fetal growth restriction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® growth hormone ÇÑ±Û ¼ºÀåÈ£¸£¸ó
¼³¸í   
  ³úÇϼöü Àü¿±¿¡¼­ ºÐºñµÇ´Â È£¸£¸óÁß Çϳª·Î¼­ ½Ã»óÇϺÎÀÇ ¼ºÀåÈ£¸£¸ó¹æÃâ È£¸£¸ó¿¡ ÀÇÇØ ºÐºñ°¡ ÀڱصǸ砼Ҹ¶Å佺Ÿƾ(somatostatin: ÀÌÀÚ¿¡¼­ ºÐºñµÇ¸ç, ¼ºÀåÈ£¸£¸ó¿¡ ¹Ý´ëµÇ´Â ÀÛ¿ëÀ» ÇÔ)¿¡ ÀÇÇØ ºÐºñ°¡ ¾ïÁ¦µÈ´Ù. ¼ºÀå È£¸£¸ó ¹æÃâ È£¸£¸óÀº µµÆÄ¹Î(dopamine)À¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ¼ºÀå È£¸£¸óÀº ¼¼Æ÷ÀÇ ¼ºÀåÀ» ÃËÁø½ÃŰ¸ç Æ¯È÷ °ñÀÇ ¼ºÀåÀ» ÀÚ±ØÇϴµ¥ ±× ÀÛ¿ëÀº Á÷Á¢ ¼¼Æ÷¿¡ ÀÛ¿ëÇϴ °ÍÀÌ ¾Æ´Ï¶ó °£°ú ±ÙÀ°¿¡ ÀÛ¿ëÇÏ¿© ±×°÷¿¡¼­ ¼Ò¸¶Åä¸ÞµòÀ» »ý¼ºÇϸç ÀÌ ¼Ò¸¶Åä¸ÞµòÀÌ ¼¼Æ÷ÀÇ ¼ºÀåÀ» ÃËÁø½ÃŲ´Ù. ÇÑÆí ¼ºÀå È£¸£¸óÀº ¼ºÀå¿¡ ÇÊ¿äÇÑ ´Ü¹éÁú ÇÕ¼ºÀ» Ç×Áø½ÃŰ°í ¿¡³ÊÁö´Â Áö¹æÀ» ÀÌ¿ëÇÏ¿© ¾ò°ÔÇϹǷΠÁö¹æÀÌ¿ëÈ£¸£¸óÀ̶ó°íµµ ºÒ¸°´Ù. ¼ºÀå È£¸£¸óÀÌ °ú´Ù ºÐºñµÇ¸é °ÅÀÎÁõ, ¸»´Üºñ´ëÁõÀÌ À¯¹ßµÇ¸ç ¼ºÀå È£¸£¸óÀÌ °áÇ̵Ǹ頼ºÀåºÎÁøÀÌ ¿Â´Ù.
¿µ¹® growth factor ÇÑ±Û ¼ºÀåÀÎÀÚ
¼³¸í   
  ¼¼Æ÷ÀÇ ºÐÈ­ ¹× ¼ºÀå¿¡ °ü¿©Çϴ ´Ü¹éÁú. ¼ºÀåÀÎÀڴ Á¤»ó ¼¼Æ÷Áֱ⿡ ÇʼöÀûÀ̱⠶§¹®¿¡ µ¿¹°ÀÇ »ý¸í¿¡ Áß´ëÇÑ ¿ä¼Ò°¡ µÈ´Ù. ¹«¾ùº¸´Ùµµ ¼ºÀåÀÎÀڴ Å¾ÆÀÇ ¹ßÀ°À» Á¶Á¤Çϰí Á¶Á÷ÀÇ À¯Áö ¹× º¸¼ö¿¡ Áß´ëÇÑ ¿ªÇÒÀ» Çϸç, Ç÷±¸ÀÇ »ý¼ºÀ» ÀÚ±ØÇÑ´Ù. ¶ÇÇÑ ¾ÏÀÇ ÁøÇà°úÁ¤¿¡µµ °ü¿©ÇÑ´Ù.
¿µ¹® fetal monitoring ÇÑ±Û Å¾ư¨½Ã
¼³¸í   
  ÀӽŠÁßÀ̳ª ºÐ¸¸ ÁßÀǠžÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â °ÍÀ» Å¾ư¨½Ã¶ó°í ÇÑ´Ù. ¿©±â¿¡´Â ¿©·¯ °¡Áö ¹æ¹ýÀÌ Àִµ¥ Å©°Ô ºÐ¸¸Àü Å¾ư¨½Ã¿Í ºÐ¸¸Áߠžư¨½Ã·Î Å©°Ô ³ª´«´Ù.
  
  1. ºÐ¸¸Àü Å¾ư¨½Ã´Â ºÐ¸¸Çϱâ ÀÌÀüÀǠžÆÀÇ »óŸ¦ °Ë»çÇϴ ¹æ¹ýÀ¸·Î ´ÙÀ½°ú °°Àº ¿©·¯ °¡Áö ¹æ¹ýÀÌ ÀÖ´Ù.
  
    1)¾ç¼öõÀÚ-ÁÖ»ç±â¸¦ ÀÌ¿ëÇØ¼­ »ê¸ðÀÇ ¹è¸¦ ÅëÇØ¼­ ¾ç¼ö¸¦ ¾ò¾î¼­ ºÐ¼®ÇÏ¿© Å¾ÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â ¹æ¹ý. ÀӽŠ15ÁÖ À̻󿡼­ ½Ç½ÃÇÒ ¼ö°¡ ÀÖ´Ù.
  
    2)ÅÈÁÙõÀÚ-ÃÊÀ½ÆÄ°Ë»ç¸¦ ½Ç½ÃÇÏ¿© ¿µ»óÀ» º¸¸é¼­ ÅÈÁÙ¼Ó¿¡ ¹Ù´ÃÀ» ³Ö¾î¼­ ±×°÷ÀÇ Ç÷°üÀ» Ã£¾Æ Ç÷¾×À» Ã¤ÃëÇÏ¿© °Ë»çÇϴ ¹æ¹ý.
  
    3)½ºÆ®·¹½º°Ë»ç-žƵµ Àڱüӿ¡¼­ ¿îµ¿À» ÇÑ´Ù. ±×¸®°í Á¤»óÀûÀ¸·Î Å¾ư¡ Àڱüӿ¡¼­ ¿îµ¿À» ÇÒ °æ¿ì¿¡´Â Å¾ÆÀÇ ½ÉÀå ¹Úµ¿ÀÌ »¡¶óÁö°Ô µÈ´Ù. Å¾ÆÀÇ ¿îµ¿°ú Å¾ÆÀÇ ½ÉÀå¹Úµ¿À» µ¿½Ã¿¡ °¨½ÃÇÏ¿© ¿îµ¿½Ã¿¡ Å¾ÆÀÇ ½ÉÀå¹Úµ¿ÀÌ »¡¶óÁö´Â °¡¸¦ ¾Ë¾Æº¸´Â °ÍÀÌ´Ù.
  
    4)žÆÃ»°¢Àڱذ˻ç-30ÁÖ ÀÌ»óÀÌ µÈ Å¾ƴ ¼Ò¸®ÀÇ Àڱؿ¡ ´ëÇØ¼­ ¹ÝÀÀÀ» ÇÑ´Ù. Áï ¼Ò¸®¸¦ µé·ÁÁÖ¾úÀ» °æ¿ì¿¡ Å¾ư¡ ¹ÝÀÀÀ» Çؼ­ ½ÉÀåÀÇ ¹Úµ¿¼ö°¡ Áõ°¡¸¦ ÇÑ´Ù.
  
    5)¼öÃེƮ·¹½º°Ë»ç-Á¤»óÀûÀΠžƴ ÀÚ±ÃÀÌ ¼öÃàÇϸé ÀÌ¿¡ ¹ÝÀÀÀ» Çؼ­ ½É¹Ú¼ö°¡ º¯È­ÇÑ´Ù. À̰ÍÀ» ÀÌ¿ëÇÏ¿© Å¾ÆÀÇ »óŸ¦ °Ë»çÇϴ ¹æ¹ýÀÌ´Ù.
  
  2. ºÐ¸¸Áߠžư¨½Ã
  
  ºÐ¸¸µµÁß¿¡ Å¾ÆÀÇ °Ç°­»óŸ¦ °¨½ÃÇϴ °ÍÀÌ´Ù. ´ëü·Î ºÐ¸¸µµÁß¿¡ Å¾ư¡ Àú»ê¼ÒÁõÀ̳ª ¿©·¯ °¡Áö Ãæ°ÝÀ» ¹Þ´Â °æ¿ì°¡ ¸¹À¸¹Ç·Î ºÐ¸¸µµÁßÀǠžư¨½Ã´Â Áß¿äÇÑ Àǹ̸¦ °¡Áø´Ù.
  
    1)ÀüÀڽĞư¨½Ã-Àü±âÀû ÀåÄ¡¸¦ ÀÌ¿ëÇÏ¿© Å¾ÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â °ÍÀ¸·Î °¨½ÃÀÇ ´ë»óÀº ÀÚ±ÃÀÇ ¼öÃà°ú Å¾ÆÀÇ ½ÉÀå¹Úµ¿¼öÀÌ´Ù.
  
    2)žƸӸ®µ¤°³ Ç¥º»Ã¤Ãë Ç÷¾×-ºÐ¸¸µµÁß¿¡ Å¾ÆÀÇ µÎÇÇÀÇ Ç÷°ü¿¡¼­ Ç÷¾×À» Ã¤ÃëÇÏ¿© °Ë»ç¸¦ ÅëÇØ¼­ Å¾ÆÀÇ »óŸ¦ ¾Æ´Â ¹æ¹ýÀÌ´Ù. ÁַΠ°Ë»ç¸¦ ÇàÇϴ Á¾¸ñÀº Ç÷¾×ÀÇ pHÀÌ´Ù.
¿µ¹® fetal assessment ÇÑ±Û Å¾ƻçÁ¤
¼³¸í   
  ÀӽŠÁßÀ̳ª ºÐ¸¸ ÁßÀǠžÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â °ÍÀ» Å¾ư¨½Ã¶ó°í ÇÑ´Ù. ¿©±â¿¡´Â ¿©·¯ °¡Áö ¹æ¹ýÀÌ Àִµ¥ Å©°Ô ºÐ¸¸Àü Å¾ư¨½Ã¿Í ºÐ¸¸Áߠžư¨½Ã·Î Å©°Ô ³ª´«´Ù. 1. ºÐ¸¸Àüžư¨½Ã: ºÐ¸¸Çϱâ ÀÌÀüÀǠžÆÀÇ »óŸ¦ °Ë»çÇϴ ¹æ¹ýÀ¸·Î ´ÙÀ½°ú °°Àº ¿©·¯ °¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ¨ç ¾ç¼öõÀÚ: ÁÖ»ç±â¸¦ ÀÌ¿ëÇØ¼­ »ê¸ðÀÇ ¹è¸¦ ÅëÇØ¼­ ¾ç¼ö¸¦ ¾ò¾î¼­ ºÐ¼®ÇÏ¿© Å¾ÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â ¹æ¹ý. ÀӽŠ15ÁÖ À̻󿡼­ ½Ç½ÃÇÒ ¼ö ÀÖ´Ù. ¨è ÅÈÁÙõÀÚ: ÃÊÀ½ÆÄ°Ë»ç¸¦ ½Ç½ÃÇÏ¿© ¿µ»óÀ» º¸¸é¼­ ÅÈÁÙ ¼Ó¿¡ ¹Ù´ÃÀ» ³Ö¾î¼­ ±× °÷ÀÇ Ç÷°üÀ» Ã£¾Æ Ç÷¾×À» Ã¤ÃëÇÏ¿© °Ë»çÇϴ ¹æ¹ý. ¾ÆÁÖ À§ÇèÇÒ °Í °°Áö¸¸ »ó´çÈ÷ ¾ÈÀüÇÑ °ÍÀ¸·Î µÇ¾î ÀÖ´Ù. ´Ù¸¥ °Ë»ç¿¡ ºñÇØ¼­ °Ë»ç¿¡ ¸¹Àº ±â¼úÀÌ ÇÊ¿äÇÏÁö¸¸ ¾ÆÁÖ ¸¹Àº Á¤º¸¸¦ Á¦°øÇØ ÁØ´Ù. ¨é ºñ½ºÆ®·¹½º°Ë»ç(nonstress test) : Å¾Ƶµ Àڱà¼Ó¿¡¼­ ¿îµ¿À» ÇÑ´Ù. ±×¸®°í Á¤»óÀûÀ¸·Î Å¾ư¡ Àڱà¼Ó¿¡¼­ ¿îµ¿À» ÇÒ °æ¿ì¿¡´Â Å¾ÆÀÇ ½ÉÀå ¹Úµ¿ÀÌ »¡¶óÁö°Ô µÈ´Ù. Å¾ÆÀÇ ¿îµ¿°ú Å¾ÆÀÇ ½ÉÀå¹Úµ¿À» µ¿½Ã¿¡ °¨½ÃÇÏ¿© ¿îµ¿½Ã¿¡ Å¾ÆÀÇ ½ÉÀå¹Úµ¿ÀÌ »¡¶óÁö´Â °¡¸¦ ¾Ë¾Æº¸´Â °ÍÀÌ´Ù.
¿µ¹® fetal alcohol syndrome ÇÑ±Û Å¾ƾËÄÚ¿ÃÁõÈıº
¼³¸í   
  ÀӽűⰣ Áß ¸¸¼ºÀûÀ¸·Î ¾ËÄÚ¿ÃÀ» ¼·ÃëÇÑ ¿©ÀÚ¿¡°Ô¼­ Å¾ ¿µ¾Æ¿¡°Ô ³ªÅ¸³ª´Â ÇüŹ߻ýÀÇ ÀÌ»óÀ» ³ªÅ¸³»´Â ÁõÈıºÀ¸·Î¼­ À§ÅλÀ¹ßÀ°ºÎÀü, ¾Õ¸Ó¸®¿Í ¾Æ·¡ÅÎÀÇ µ¹Ãâ, ÂªÀº°Ë¿­, ÀÛÀº¾È±¸Áõ, ´«±¸¼®ÁÖ¸§, ½ÉÇÑ ¼ºÀåÁö¿¬, Á¤½ÅÁöü µîÀ» ³ªÅ¸³½´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • asymmetric fetal growth restriction
    ºñ´ëĪžƼºÀåÁ¦ÇÑ
  • intrauterine growth restriction
    Àڱ󻼺ÀåÁ¦ÇÑ
  • fetal growth retardation
    žƼºÀåÁö¿¬
  • genetic restriction
    À¯Àü»óÈ£ÀÛ¿ëÁ¦ÇÑ
  • restriction
    Á¦ÇÑ
  • restriction endonuclease
    Á¦ÇÑÇÙ¼ÓÇÙ»êºÐÇØÈ¿¼Ò, Á¦ÇÑ¿£µµ´ºÅ¬·¹¾ÆÁ¦
  • restriction enzyme
    Á¦ÇÑÈ¿¼Ò
  • restriction fragment length polymorphism
    Á¦ÇÑÀýÆí±æÀÌ´ÙÇüÅÂ
  • restriction map
    Á¦ÇÑÈ¿¼ÒÁöµµ
  • definitive fetal membrane
    ¿Ï¼ºÅ¾Ƹ·, È®Á¤Å¾Ƹ·
  • definitive fetal period
    žƿϼº±â
  • early fetal death
    Á¶±âžƻç¸Á
  • fetal
    žÆ-
  • fetal alcohol syndrome
    žƾËÄÚ¿ÃÁõÈıº
  • fetal anemia
    žƺóÇ÷
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • intrauterine growth restriction
    Àڱ󻼺ÀåÁö¿¬
  • restriction enzyme
    Á¦ÇÑÈ¿¼Ò
  • restriction map
    Á¦ÇÑÈ¿¼ÒÁöµµ
  • restriction
    Á¦ÇÑ
  • salt restriction
    ¿°ºÐÁ¦ÇÑ
  • water restriction
    ¹°Á¦ÇÑ, ¼öºÐÁ¦ÇÑ
  • growth factor
    ¼ºÀåÀÎÀÚ
  • nerve growth factor
    ½Å°æ¼ºÀåÀÎÀÚ
  • platelet-derived growth factor
    Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
  • transforming growth factor
    Àüȯ¼ºÀåÀÎÀÚ
  • vascular endothelial growth factor
    Ç÷°ü³»ÇǼºÀåÀÎÀÚ
  • growth
    ¼ºÀå, Áõ½Ä
  • growth spurt
    ¼ºÀå±ÞÁõ
  • peak growth velocity
    Ãִ뼺Àå¼Óµµ
  • growth zone
    ¼ºÀ屸¿ª
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fetal growth retardation
    žƼºÀåÁö¿¬
  • restriction endonuclease
    Á¦ÇÑÀûÇÙ¼ÓÇÙ»êºÐÇØÈ¿¼Ò, Á¦ÇÑÀû¿£µµ´ºÅ¬·¹¾ÆÁ¦
  • restriction enzyme
    Á¦ÇÑÈ¿¼Ò
  • genetic restriction
    À¯ÀüÀû»óÈ£ÀÛ¿ëÁ¦ÇÑ
  • haplotype restriction
    ÀϹè¼öüÁ¦ÇÑ
  • restriction map
    Á¦ÇÑÈ¿¼ÒÁöµµ
  • restriction fragment length polymorphism
    Á¦ÇÑÀýÆí±æÀÌ´ÙÇü¼º
  • restriction
    Á¦ÇÑ
  • restriction endonuclease
    Á¦ÇÑÇٻ곻ºÎ°¡¼öºÐÇØÈ¿¼Ò
  • sleep position restriction
    ¼ö¸éÀÚ¼¼Á¦ÇÑ
  • fetal appendage
    žƺμӱâ°ü
  • fetal asphyxia
    žÆÁú½Ä
  • fetal suction obstetrical apparatus
    žÆÈíÀÎÁ¶»ê±â, žÆÈíÀκи¸±â
  • fetal heart beat
    žƽÉÀå¹Úµ¿
  • fetal circulation
    žƼøÈ¯
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Ia restriction
    IaÂ÷À̼ö¹Ý ¸é¿ª»óÈ£ÀÛ¿ëÁ¦ÇÑ
  • haplotype restriction
    ÁÖÁ¶Á÷ÀûÇÕÇ׿øº¹ÇÕü¿°»öü Â÷À̼ö¹Ý ¸é¿ªÁ¦ÇÑ
  • homologous restriction factor
    µ¿Á¾Á¦ÇÑÀÎÀÚ
  • growth arrest line (=growth recovery line)
    ¼ºÀå Áö¿¬¼±
  • F hemoglobin fetal
    žƼº(÷Ãä®àõ) Çì¸ð±Û·Îºó
  • FECG= fetal electrocardiogram
    ÅÂ¾Æ½É Àüµµ.
  • Fetal circulation
    žƼøÈ¯(÷Ãä®âàü»)
  • Fetal hemoglobin
    žÆÇ÷»ö¼Ò(÷Ãä®úìßäáÈ)
  • Fetal respiration
    žÆÈ£Èí(÷Ãä®û¼ýå)
  • Fetal thyroid-stimulating hormone
    žư©»ó¼±ÀÚ±Ø(÷Ãä®Ë£ßÒàÍí©Ð½)È£¸£¸ó
  • antigen, fetal
    žÆÇ׿ø
  • antigen,fetal
    žƼº(÷Ãä®àõ)
  • antigen,fetal tumor-associated
    žÆÁ¾¾ç °ü·Ã¼º(÷Ãä®ðþåË Î¼Ö¤àõ)
  • hemoglobin, fetal =HbF
    žƼº Çì¸ð±Û·Îºó.
  • hemoglobin, fetal =HbF
    žƼºÇì¸ð±Û·Îºó
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fetal growth retardation
    ÅÂ¾Æ ¹ßÀ° Áö¿¬, ÅÂ¾Æ ¼ºÀå Áö¿¬
  • growth arrest line (=growth recovery line)
    ¼ºÀå Áö¿¬¼±
  • endonuclease, restriction
    Á¦ÇÑÈ¿¼Ò
  • enzyme, restriction
    Á¦ÇÑÈ¿¼Ò
  • haplotype restriction
    ÁÖÁ¶Á÷ÀûÇÕÇ׿øº¹ÇÕü¿°»öü Â÷À̼ö¹Ý ¸é¿ªÁ¦ÇÑ
  • homologous restriction factor
    µ¿Á¾Á¦ÇÑÀÎÀÚ
  • legal restriction
    ¹ýÀûÇѰè(¡­ùÚÍ£).
  • legal restriction
    ¹ýÀûÇѰè(ÊṴ̀˭).
  • mst ii restriction enzyme
    Mst II Á¦ÇÑÈ¿¼Ò(¡­ ð¤ùÚý£áÈ)
  • restriction analysis
  • restriction endonuclease
    Á¦ÇÑ¿£µµ´ºÅ¬¸®¿¡ÀÌÁî
  • restriction endonuclease
    Á¦ÇÑÈ¿¼Ò
  • restriction endonucleases
    Á¦ÇÑÇÙ»ê ³»ºÎ°¡¼öºÐÇØÈ¿¼Ò
  • restriction enzyme
    Á¦ÇÑÈ¿¼Ò
  • restriction enzyme
    Á¦ÇÑÈ¿¼Ò(ð¤ùÚý£áÈ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Appositional growth
    µ¡ºÙÀ̼ºÀå
    [¿¾ ¿ë¾î] ÷°¡¼ºÀå
  • Abnormal growth
    ºñÁ¤»ó¼ºÀå
    [¿¾ ¿ë¾î] ºñÁ¤»ó¼ºÀå
  • Interstitial growth
    »çÀÌÁú¼ºÀå
    [¿¾ ¿ë¾î] °£Áú¼ºÀå
  • Growth abnormality
    ¼ºÀåÀÌ»ó
    [¿¾ ¿ë¾î] ¼ºÀåÀÌ»ó
  • Growth defect
    ¼ºÀå°áÇÔ
    [¿¾ ¿ë¾î] ¼ºÀå°áÇÔ
  • Growth cone
    ¼ºÀå¿ø»Ô
    [¿¾ ¿ë¾î] ¼ºÀå¿øÃß
  • Fetal inclusion
    ºÀÀÔžÆ
    [¿¾ ¿ë¾î] ºÀÀÔ±âÇüžÆ
  • Vitamin deficiency (Fetal osteodystrophy)
    ºñŸ¹Î°áÇÌ(žƻÀ¿µ¾çÀå¾Ö)
    [¿¾ ¿ë¾î] ºñŸ¹Î°áÇÌ(žƻÀ¿µ¾çÀå¾Ö)
  • Fetal period
    žƱâ
    [¿¾ ¿ë¾î] žƱâ
  • Defect of fetal membrane
    žƸ·°áÇÔ
    [¿¾ ¿ë¾î] Ÿ·°áÇÔ
  • Fetal part
    žƺκÐ
    [¿¾ ¿ë¾î] žƺÎ
  • Fetal parts
    žƺκÐ
    [¿¾ ¿ë¾î] žƺÎ
  • Definitive fetal period
    žƿϼº±â
    [¿¾ ¿ë¾î] žƿϼº±â
  • Fetal cotyledon
    žÆÂÊŹݿ±
    [¿¾ ¿ë¾î] žÆÃøÅ¹ݿ±
  • Initial fetal period
    žÆÃʱâ
    [¿¾ ¿ë¾î] žÆÀü±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fetal hemoglobin
    žÆ(÷Ãä®) È÷¸ð±Û·Îºó
  • DNA restriction enzyme
    DNA Á¦ÇÑ È¿¼Ò(ð¤ùÚý£áÈ) (ÔÒ) restriction enzyme
  • host-controlled restriction
    ¼÷ÁÖÁ¦¾î Á¦ÇÑ(âÖñ«ð¤åÙð¤ùÚ)
  • modification and restriction
    ¼ö½Ä(áóãÞ)°ú Á¦ÇÑ(ð¤ùÚ)
  • restriction
    Á¦ÇÑ(ð¤ùÚ)
  • restriction allele
    Á¦ÇÑ ´ë¸³À¯ÀüÀÚ(Óߨ¡ë¶îîí­)
  • restriction endonuclease
    Á¦ÇÑ ¿£µµ´ºÅ¬¸®¿¡À̽º
  • restriction enzyme
    Á¦ÇÑÈ¿¼Ò(ð¤ùÚý£áÈ)
  • restriction fragment
    Á¦ÇÑ Á¶°¢
  • restriction fragment length polymorphism
    Á¦ÇÑ Á¶°¢±æÀÌ ´ÙÇü¼º(Òýúþàõ)
  • restriction gene
    Á¦ÇÑ À¯ÀüÀÚ(ë¶îîí­)
  • restriction map
    Á¦ÇÑ Áöµµ(ò¢Óñ)
  • restriction-modification system
    Á¦ÇÑ ¼ö½Ä(áóãÞ) ½Ã½ºÅÛ
  • restriction mutant
    Á¦ÇÑ º¯ÀÌü(ܨì¶ô÷)
  • restriction point
    Á¦ÇÑÁ¡(ð¤ùÚïÃ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • restriction
    ÇÑ, Á¦ÇÑ
  • fetal
    žÆÀÇ, ų»ÀÇ
  • fetal circulation
    žƼøÈ¯, žÆÇ÷Çà
  • fetal death
    žƻç¸Á
  • fetal distress syndrome
    žưï¶õÁõÈıº
  • fetal hemoglobin
    žƼºÇì¸ð±Û·Îºó, žƼºÇ÷»ö¼Ò
  • fetal position
    ÅÂÀ§
  • fetal sac
    ų¶
  • growth
    ¼ºÀå
  • growth abnormality
    ¹ßÀ°ÀÌ»ó
  • growth and development
    ¼ºÀå°ú ¹ßÀ°
  • growth arrest line
    ¼ºÀåÁö¿¬¼±
  • growth curve
    Áõ½Ä°î¼±, ¼ºÀå°î¼±
  • growth hormone
    ¼ºÀåÈ£¸£¸ó
  • growth line
    ¼ºÀå¼±
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HCG, hCG Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  1. Placental Glycoprotein Hormone
&nbs...
NG nasogastric; neoplastic growth; new growth; nitroglycerin; nodose ganglion; no growth; not given
TGF T-cell growth factor; transforming growth factor; tuboglomerular feedback; tumor growth factor
RFLPs Restriction Fragment Length Polymorphisms; Á¦ÇÑÈ¿¼Ò´ÜÆíÀå´ÙÇü
FR failure rate; film-screen radiograph; fasciculus retroflexus; febrile reaction; feedback regulation;...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FGR Fetal growth restriction
IUGR Intrauterine growth restriction
FGR Fetal growth retardation
HB-EGF Heparin binding epidermal growth factor-like growth factor
HB-EGF Heparin-binding epidermal growth factor (EGF)-like growth factor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • IGF-I : insulin like growth factor-IÀÇ ¾àÀÚ. ¼ºÀåÆÇÀÎ epiphyseal plate¿¡ ¿¬°ñ »ý¼ºÀ» Áõ°¡½ÃÄÑ »ÀÀÇ ¼ºÀåÀ» ÃËÁøÇÑ´Ù.

    IGF-II : insulin like growth factor-IIÀÇ ¾àÀÚ. ¸¹Àº Àå±â¿Í Á¶Á÷¿¡ ÀÛ¿ëÇÏ¿© ´Ü¹é ÇÕ¼º°ú DNA, RNAÀÇ ÇÕ¼ºÀ» Áõ°¡½ÃÄÑ ¼¼Æ÷ÀÇ ¼ö¿Í ¾çÀ» Áõ°¡

    Àν¶¸°¾ç ¼ºÀå ÀÎÀÚ °áÇÕ ´Ü¹éÁú
    insulinelike growth factor binding
  • extracapsular restriction
    °üÀý³¶¿Ü Á¦ÇÑ, °üÀý³¶¿Ü °³±¸ Á¦ÇÑ
  • restriction
    °³±¸ Á¦ÇÑ, Á¦ÇÑ
  • abnormal fetal presentation
    ÀÌ»ó ÅÂÀ§
    žÆÀÇ À§Ä¡°¡ ºñÁ¤»óÀûÀÎ °Í.
  • fetal alcohol
    ÅÂ¾Æ ¾ËÄÝ
  • fetal antigen
    ÅÂ¾Æ Ç׿ø
    Á¾¾ç °ü·Ã Ç׿øÀÇ ÀÏÁ¾, Å»ý±â Á¶Á÷¿¡¼­´Â ÀÎÁ¤µÇÁö¸¸, Á¤»óÀûÀÎ ºÐÈ­¸¦ ¹âÀº Á¶Á÷¿¡¼­´Â ÀÎÁ¤µÇÁö ¾Ê°Å³ª ±ØÈ÷ ¹Ì·® Á¸ÀçÇϰųª ÇÑ´Ù.
  • fetal cartilage
    ų» ¿¬°ñ
  • fetal cretinism
    ÅÂ¾Æ °©»ó¼± ±â´É ÀúÇÏÁõ
  • fetal distress syndrome
    ÅÂ¾Æ °ï¶õ ÁõÈıº
  • fetal hemoglobin
    žƼº Çì¸ð±Û·Îºó
  • fetal liver cell
    ÅÂ¾Æ °£ ¼¼Æ÷
    ÅÂ¾Æ °£ ¼¼Æ÷, Á¶Ç÷ stem ¼¼Æ÷°¡ µé¾î ÀÖ°í, µû¶ó¼­ °¢Á¾ ¸é¿ª ¼¼Æ÷ÀÇ Àü±¸ ¼¼Æ÷¸¦ Æ÷ÇÔÇÑ´Ù. ÃÖ±Ù ¸é¿ªºÎÀüÀÇ Áúȯ, ¿¹¸¦ µé¸é ÁßÁñ º¹ÇÕ ¸é¿ª ºÎÀüÁõ¿¡¼­´Â Á¶Á÷ ÀûÇÕ °ñ¼ö¸¦ ¾òÁö ¸øÇÏ´Â °æ¿ì, 8ÁÖ ÀÌÀüÀÇ ÅÂ¾Æ °£¼¼Æ÷ÀÇ À̽ÄÀÌ ÀÌ·ç¾îÁ® Àå±â°£ÀÇ »ýÁ¸ ¿¹¸¦ º¼ ¼ö ÀÖ´Ù.
  • fetal placental-maternal interrelation
    žÆ-ŹÝ-¸ðü »óÈ£ °ü°è
  • fetal pseudoascites
    žÆÀÇ °¡¼º º¹¼ö
  • human fetal membrane
    »ç¶÷ ÅÂ¾Æ ¸·
  • abnormal growth
    ºñÁ¤»ó ¼ºÀå
    ¼ºÀåÀÌ Á¤»óÀûÀÎ ¹üÀ§¸¦ ¹þ¾î³­ »óÅÂ. Á¤»óº¸´Ù »¡¸® ÀÚ¶ö ¼öµµ ÀÖ°í ´Ê°Ô ÀÚ¶ö ¼öµµ ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
fetal Of or pertaining to a foetus, pertaining to in utero development after the embryonic period.
(18 Nov 1997)
cell cycle restriction point <cell biology, molecular biology> A point, late in G1, after which the cell must, normally, proceed through to division at its standard rate.
(26 Mar 1998)
restriction 1. The process with which foreign DNA that has been introduced into a prokaryotic cell becomes ineffective.
2. A limitation.
(05 Mar 2000)
restriction endonuclease <enzyme, molecular biology> Class of bacterial enzymes that cut DNA at specific sites. In bacteria their function is to destroy foreign DNA, such as that of bacteriophages (host DNA is specifically modified at these sites).
Type I restriction endonucleases occur as a complex with the methylase and a polypeptide that binds to the recognition site on DNA. They are often not very specific and cut at a remote site.
Type II restriction endonucleases are the classic experimental tools. They have very specific recognition and cutting sites. The recognition sites are short, 4-8 nucleotides and are usually palindromic sequences. Because both strands have the same sequence running in opposite directions the enzymes make double stranded breaks, which, if the site of cleavage is off centre, generates fragments with short single stranded tails, these can hybridise to the tails of other fragments and are called sticky ends.
They are generally named according to the bacterium from which they were isolated (first letter of genus name and the first two letters of the specific name). The bacterial strain is identified next and multiple enzymes are given Roman numerals. For example the two enzymes isolated from the R strain of E. Coli are designated Eco RI and Eco RII.
(10 Mar 1998)
restriction enzyme <enzyme, molecular biology> Class of bacterial enzymes that cut DNA at specific sites. In bacteria their function is to destroy foreign DNA, such as that of bacteriophages (host DNA is specifically modified at these sites).
Type I restriction endonucleases occur as a complex with the methylase and a polypeptide that binds to the recognition site on DNA. They are often not very specific and cut at a remote site.
Type II restriction endonucleases are the classic experimental tools. They have very specific recognition and cutting sites. The recognition sites are short, 4-8 nucleotides and are usually palindromic sequences. Because both strands have the same sequence running in opposite directions the enzymes make double stranded breaks, which, if the site of cleavage is off centre, generates fragments with short single stranded tails, these can hybridise to the tails of other fragments and are called sticky ends.
They are generally named according to the bacterium from which they were isolated (first letter of genus name and the first two letters of the specific name). The bacterial strain is identified next and multiple enzymes are given Roman numerals. For example the two enzymes isolated from the R strain of E. Coli are designated Eco RI and Eco RII.
(10 Mar 1998)
restriction enzyme cutting site <molecular biology> A specific nucleotide sequence of DNA at which a particular restriction enzyme cuts the DNA.
Some sites occur frequently in DNA (for example, every several hundred basepairs), others much less frequently (rare-cutter, for example, every 10,000 base pairs).
(10 Mar 1998)
restriction enzyme, endonuclease A protein that recognises specific, short nucleotide sequences and cuts DNA at those sites. Bacteria contain over 400 such enzymes that recognise and cut over 100 different DNA sequences. See restriction enzyme cutting site.
(05 Mar 2000)
restriction fragment <molecular biology> The fragments of DNA generated by digesting DNA with a specific restriction endonuclease. Each of the fragments ends in a site recognised by that specific enzyme.
(10 Mar 1998)
restriction fragment length polymorphism <molecular biology, technique> A method that allows familial relationships to be established by comparing the characteristic polymorphic patterns that are obtained when certain regions of genomic DNA are amplified (typically by PCR) and cut with certain restriction enzymes.
The variation in the length of DNA fragments produced by a restriction endonuclease that cuts at a polymorphic locus. Such variations are generated by mutations that create or abolish recognition sites for these enzymes.
This is a key tool in DNA fingerprinting, reflecting the existence of different alleles in the individual. Restriction fragment length polymorphism mapping is also used in plant breeding to see if a key trait such as disease resistance is inherited.
In principle, an individual can be identified unambiquously by restriction fragment length polymorphism hence the use of restriction fragment length polymorphism in forensic analysis of blood, hair or semen).
Similarly, if a polymorphism can be identified close to the locus of a genetic defect, it provides a valuable marker for tracing the inheritance of the defect.
Synonym: DNA fingerprinting.
Acronym: RFLP
(12 Jan 1998)
restriction length polymorphism Fragment length polymorphism, the existence of allelic forms recognizable by the length of fragments that result when the nucleotide chain is treated by a specific restriction enzyme that cleaves wherever a particular sequence of nucleotides occurs. A mutation in this sequence changes cleaving and hence the number of fragments.
(05 Mar 2000)
restriction map <molecular biology> Map of DNA showing the position of sites recognised and cut by various restriction endonucleases.
(12 Jan 1998)
restriction mapping Use of restriction endonucleases to analyze and generate a physical map of genomes or genes. The nucleotide sequence determined is often then translated into an amino acid sequence, providing a means for sequencing the protein for which the gene codes, or for which the mRNA is a messenger.
(12 Dec 1998)
restriction methylation The enzymatic addition of methyl groups to selected adenine and cytosine residues to protect from hydrolysis by certain restriction enzymes.
(05 Mar 2000)
restriction nuclease <enzyme, molecular biology> Class of bacterial enzymes that cut DNA at specific sites. In bacteria their function is to destroy foreign DNA, such as that of bacteriophages (host DNA is specifically modified at these sites).
Type I restriction endonucleases occur as a complex with the methylase and a polypeptide that binds to the recognition site on DNA. They are often not very specific and cut at a remote site.
Type II restriction endonucleases are the classic experimental tools. They have very specific recognition and cutting sites. The recognition sites are short, 4-8 nucleotides and are usually palindromic sequences. Because both strands have the same sequence running in opposite directions the enzymes make double stranded breaks, which, if the site of cleavage is off centre, generates fragments with short single stranded tails, these can hybridise to the tails of other fragments and are called sticky ends.
They are generally named according to the bacterium from which they were isolated (first letter of genus name and the first two letters of the specific name). The bacterial strain is identified next and multiple enzymes are given Roman numerals. For example the two enzymes isolated from the R strain of E. Coli are designated Eco RI and Eco RII.
(10 Mar 1998)
restriction site A sequence in DNA that can be recognised and cut by a specific restriction enzyme.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fetal
    žÆÀÇ
  • fetal hemoglobin
    žƼº Ç÷»ö¼Ò;žƼº Çì¸ð±Û·Îºó
  • fetal position
    žÆÇü ÀÚ¼¼
  • restriction
    Á¦ÇÑ
  • import restriction
    ¼öÀÔÁ¦ÇÑ(±ÔÁ¦)
  • restriction
    Á¦ÇÑ;ÇÑÁ¤;±¸¼Ó;¼Ó¹Ú;Á¦ÇÑ(Á¦¾à)ÇÏ´Â °Í;»ç¾ç
  • restriction endonuclease
    =RESTRICTION ENZYME
  • restriction enzyme
    Á¦ÇÑ È¿¼Ò(µÎÁÙ »ç½½ DNA¸¦ ƯÁ¤ ºÎÀ§¿¡¼­ Àý´ÜÇÏ´Â È¿¼Ò)
  • restriction site
    Á¦ÇÑ ºÎÀ§(Á¦ÇÑ È¿¼Ò°¡ Àý´ÜÇÏ´Â µÎ ÁÙ »ç½½ DNA»óÀÇ ºÎÀ§)
  • growth
    ¼ºÀå,¹ß´Þ,Áõ°¡
  • economic growth rate
    °æÁ¦ ¼ºÀå·ü 9
  • growth
    ¼ºÀå;»ýÀå;¹ßÀ°;¹ß´Þ;Áõ´ë;Àç¹è;»ýÀå(¹ß»ý)¹°;»ê¹°
  • growth center
    (sensitivity trainingµîÀ»ÇÏ´Â)´É·Â °³¹ß ¼¾ÅÍ)
  • growth hormone
    ¼ºÀå È£¸£¸ó 
  • growth industry
    ¼ºÀå »ê¾÷
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á